# Antipsychotic Effects on Brain Function in Schizophrenia

> **NCT01913327** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 4 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Risperidone
- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT01913327
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Insufficient Funds and Inadequate Subject Recruitment
- **Last updated:** 2020-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913327, "Antipsychotic Effects on Brain Function in Schizophrenia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01913327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*